Meta-Analysis Assessing the Impact of Major Co-Morbidities, Gender, and Race on Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors Among Patients With Heart Failure With Preserved or Reduced Ejection Fraction.

Dimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas

Journal: The American journal of cardiology 2022;162():201-205

PMID: 34688474

Full Text on Elsevier Science View on PubMed

Abstract

Address: Second Propedeutic Department of Internal Medicine.; Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.; Second Propedeutic Department of Internal Medicine; Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia.

DOI: 10.1016/j.amjcard.2021.09.029

Link outs

Free resources

Medical:

https://medlineplus.gov/heartfailure.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Female, Heart Failure, Humans, Male, Race Factors, Sex Factors, Sodium-Glucose Transporter 2 Inhibitors, Stroke Volume, Treatment Outcome